Aducanumab: A Promising New Drug That May Halt Memory Decline
Though still in the early stages of clinical trials, a new drug, aducanumab, is showing promise in breaking down the amyloid plaques that build up in the brains of individuals diagnosed with Alzheimer's disease. Biogen, the drug’s developer, reported that [View More]